Literature DB >> 14695789

Isolation and structure elucidation of Sch 642305, a novel bacterial DNA primase inhibitor produced by Penicillium verrucosum.

Min Chu1, Ronald Mierzwa, Ling Xu, Ling He, Joseph Terracciano, Mahesh Patel, Vincent Gullo, Todd Black, Wenjun Zhao, Tze-Ming Chan, Andrew T McPhail.   

Abstract

A novel primase inhibitor, Sch 642305 (1), was isolated from the fermentation broth of the fungal culture Penicillium verrucosum. The structure of 1 was elucidated on the basis of MS and NMR spectroscopic data as a new and unusual bicyclic 10-membered macrolide. The absolute configuration of the asymmetric centers was determined by X-ray crystallographic analysis of the p-bromobenzoate derivative (3). Compound 1 exhibited inhibitory activity against bacterial DNA primase enzyme with an EC(50) of 70 microM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695789     DOI: 10.1021/np0302302

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

1.  Quasi-Biomimetic Ring Contraction Catalyzed by a Cysteine-Based Nucleophile: Total Synthesis of Sch-642305, Some Analogs and their Putative anti-HIV Activities.

Authors:  Alpay Dermenci; Philipp S Selig; Robert A Domaoal; Krasimir A Spasov; Karen S Anderson; Scott J Miller
Journal:  Chem Sci       Date:  2011-08-01       Impact factor: 9.825

2.  Synthesis of (+)-sch 642305 by a biomimetic transannular Michael reaction.

Authors:  Barry B Snider; Jingye Zhou
Journal:  Org Lett       Date:  2006-03-30       Impact factor: 6.005

Review 3.  Asymmetric Catalysis Mediated by Synthetic Peptides, Version 2.0: Expansion of Scope and Mechanisms.

Authors:  Anthony J Metrano; Alex J Chinn; Christopher R Shugrue; Elizabeth A Stone; Byoungmoo Kim; Scott J Miller
Journal:  Chem Rev       Date:  2020-09-24       Impact factor: 60.622

Review 4.  Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.

Authors:  Andrew Robinson; Rebecca J Causer; Nicholas E Dixon
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

Review 5.  The Macromolecular Machines that Duplicate the Escherichia coli Chromosome as Targets for Drug Discovery.

Authors:  Jon M Kaguni
Journal:  Antibiotics (Basel)       Date:  2018-03-14

Review 6.  Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.

Authors:  Michael A Reiche; Digby F Warner; Valerie Mizrahi
Journal:  Front Mol Biosci       Date:  2017-11-14

7.  Endophytic Fungus Isolated From Achyrocline satureioides Exhibits Selective Antiglioma Activity-The Role of Sch-642305.

Authors:  Nathalia Stark Pedra; Kennia de Cássia Araújo Galdino; Daniel Schuch da Silva; Priscila Treptow Ramos; Natália Pontes Bona; Mayara Sandrielly Pereira Soares; Juliana Hoffstater Azambuja; Kirley Marques Canuto; Edy Sousa de Brito; Paulo Riceli Vasconcelos Ribeiro; Ana Sheila de Queiroz Souza; Wilson Cunico; Francieli Moro Stefanello; Roselia Maria Spanevello; Elizandra Braganhol
Journal:  Front Oncol       Date:  2018-10-29       Impact factor: 6.244

8.  Production and fungitoxic activity of Sch 642305, a secondary metabolite of Penicillium canescens.

Authors:  Rosario Nicoletti; Maria Pilar Lopez-Gresa; Emiliano Manzo; Angela Carella; Maria Letizia Ciavatta
Journal:  Mycopathologia       Date:  2007-04-12       Impact factor: 3.785

Review 9.  DnaG Primase-A Target for the Development of Novel Antibacterial Agents.

Authors:  Stefan Ilic; Shira Cohen; Meenakshi Singh; Benjamin Tam; Adi Dayan; Barak Akabayov
Journal:  Antibiotics (Basel)       Date:  2018-08-13

Review 10.  Targeting Genome Integrity in Mycobacterium Tuberculosis: From Nucleotide Synthesis to DNA Replication and Repair.

Authors:  Riccardo Miggiano; Castrese Morrone; Franca Rossi; Menico Rizzi
Journal:  Molecules       Date:  2020-03-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.